JPMorgan Chase reaffirmed their neutral rating on shares of Merck KGaA (FRA: MRK) in a report issued on Tuesday, AnalystRatingsNetwork.com reports. They currently have a €120.00 ($155.84) target price on the stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at Morgan Stanley initiated coverage on shares of Merck KGaA in a research note to investors on Thursday, May 23rd. They set an overweight rating and a €142.00 ($184.42) price target on the stock. Separately, analysts at AlphaValue reiterated a sell rating on shares of Merck KGaA in a research note to investors on Monday, May 20th. They now have a €108.00 ($140.26) price target on the stock. Finally, analysts at Commerzbank Corporates & Markets reiterated a reduce rating on shares of Merck KGaA in a research note to investors on Thursday, May 16th. They now have a €105.00 ($136.36) price target on the stock.
Six analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average target price of €106.98 ($138.94).
Shares of Merck KGaA (FRA: MRK) traded down 0.46% during mid-day trading on Tuesday, hitting €122.48. Merck KGaA has a one year low of €72.51 and a one year high of €125.629. The stock’s 50-day moving average is currently €94.50.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.